Medical Oncology

Indiana University   

Questions discussed in this category



The patient remains without evidence of systemic disease outside of the CNS on serial imaging. Would you continue treating with SRS as lesions appear,...

What are the risks of infection with COVID-19 if using immunotherapy?  

What would be the next line of treatment, PRRT, capecitabine and temozolomide or other?

In a patient with lung cancer with both NSCLC and SCLC components, would you offer carbo/pem/pembro or carbo/etoposide/atezolizumab? Or any other alte...

There is no evidence of disease outside the lung on PET, and the patient is completely asymptomatic with negative EGFR, ALK, ROS1, and BRAF and a PD-L...


Papers discussed in this category


J. Clin. Oncol., 2020 Feb 20

N. Engl. J. Med., 2019 May 31

The New England journal of medicine, 2018-12-06

J Thorac Oncol, 2019 Jan 18

Int J Cancer, 2018 Apr 15

JAMA Oncol, 2019 Oct 31

Eur J Surg Oncol, 2014 Oct 07

Annals of surgical oncology, 2018-08

Lancet, 2019 Oct 04

The New England journal of medicine, 2018-05-31

British journal of cancer, 2005-03-14

Case Rep Oncol, 2020 Jan 21

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2013-11-01

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2009-11-01